New trial for lenalidomide in untreated, high risk CLL

[Guest guest]

This is for previously untreated, high risk patients with 11q or 17p deletions

and/or unmutated immunoglobulin heavy chain gene rearrangement.

Phase II, Roswell Park CI, Buffalo

http://clinicaltrials.gov/ct2/show/NCT01271283

~chris